220 related articles for article (PubMed ID: 11301960)
1. Considerations in the treatment of mild-to-moderate hypertension.
Giaquinta D
Manag Care Interface; 2001 Mar; 14(3):80-1. PubMed ID: 11301960
[No Abstract] [Full Text] [Related]
2. Improving prescribing practices in primary care. A randomised trial and economic analysis of a multicomponent intervention showed small, but important, gains.
Del Mar C
PLoS Med; 2006 Jun; 3(6):e229. PubMed ID: 16729845
[TBL] [Abstract][Full Text] [Related]
3. [Investigation and treatment of primary hypertension].
Lindstedt I; Nilsson PM
Lakartidningen; 2008 Jul 23-Aug 5; 105(30-31):2107-12. PubMed ID: 18751450
[No Abstract] [Full Text] [Related]
4. Health economic issues and the future treatment and management of hypertension.
Giles TD
AAPPO J; 1994; 4(4):27-8, 30, 33-5. PubMed ID: 10150589
[No Abstract] [Full Text] [Related]
5. Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service.
Marković BB; Kranjcević K; Reiner Z; Blazeković SM; Spehar SS
Croat Med J; 2005 Dec; 46(6):984-9. PubMed ID: 16342354
[TBL] [Abstract][Full Text] [Related]
6. [Research and marketing].
Meland E; Hernborg A
Tidsskr Nor Laegeforen; 2004 Jul; 124(13-14):1820. PubMed ID: 15229677
[No Abstract] [Full Text] [Related]
7. [Drug committees welcome the SBU hypertension report. A number of patients can be offered cost-effective, evidence-based therapy].
Ohlsson O
Lakartidningen; 2004 Dec; 101(49):3984-5. PubMed ID: 15633336
[No Abstract] [Full Text] [Related]
8. Economics of drug treatment.
Jackson PR
Lancet; 2002 Mar; 359(9309):892-3. PubMed ID: 11897317
[No Abstract] [Full Text] [Related]
9. An economic evaluation of the 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of mild-to-moderate hypertension in Greece.
Stafilas PC; Sarafidis PA; Lasaridis AN; Aletras VH; Niakas DA
Am J Hypertens; 2005 Sep; 18(9 Pt 1):1233-40; discussion 1241-2. PubMed ID: 16182115
[TBL] [Abstract][Full Text] [Related]
10. Discrepancies between use of antihypertensive drugs and guidelines indications: pharmacoeconomic implications.
Robbiano L; Martelli A; Brambilla G
J Hum Hypertens; 2005 Oct; 19(10):819-22. PubMed ID: 15951739
[No Abstract] [Full Text] [Related]
11. [New treatment strategies for the management of hypertension].
Reinhardt A; Linsel-Nitschke P; Schunkert H
MMW Fortschr Med; 2009 Nov; 151(46):33-6. PubMed ID: 20043391
[No Abstract] [Full Text] [Related]
12. [Selection criteria in the treatment of arterial hypertension and recommended guidelines].
Agabiti-Rosei E; Muiesan ML; Bettoni G
Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):527-32. PubMed ID: 12497777
[No Abstract] [Full Text] [Related]
13. [CBO guideline 'high blood pressure' (revision)].
de Bruijckere PA
Ned Tijdschr Geneeskd; 2002 Mar; 146(9):439; author reply 439. PubMed ID: 11901947
[No Abstract] [Full Text] [Related]
14. [CBO guideline 'high blood pressure' (revision)].
Polak BC
Ned Tijdschr Geneeskd; 2002 Mar; 146(9):439; author reply 439-40. PubMed ID: 11901948
[No Abstract] [Full Text] [Related]
15. Beta-blockers and the treatment of hypertension.
Williams B
J Hypertens; 2007 Jul; 25(7):1351-3. PubMed ID: 17563554
[No Abstract] [Full Text] [Related]
16. A retrospective analysis comparing the costs and cost effectiveness of amlodipine and enalapril in the treatment of hypertension.
Doyle J; Omvik P; Arikian S; Casciano J; Casciano R; Gonzalez MA; Arocho R
Manag Care Interface; 2001 Mar; 14(3):82-7. PubMed ID: 11301961
[TBL] [Abstract][Full Text] [Related]
17. [Mild hypertension, low risk: when to intervene?].
Holzgreve H
MMW Fortschr Med; 2005 Aug; 147(33-34):33, 35-6. PubMed ID: 16138632
[No Abstract] [Full Text] [Related]
18. Economic factors in formulating a national policy on the prevention by drugs of cardiovascular disease.
Malcolm L
N Z Med J; 1990 Aug; 103(896):402-4. PubMed ID: 2117264
[No Abstract] [Full Text] [Related]
19. Out-of-pocket costs to users: medicine options for hypertension.
Arredondo A
Am J Hypertens; 2008 May; 21(5):492. PubMed ID: 18437138
[No Abstract] [Full Text] [Related]
20. [The pharmaco-economics of the treatment of arterial hypertension: data and controversies].
Rorive G; Delporte JP
Bull Mem Acad R Med Belg; 1998; 153(7-9):317-21; discussion 322-4. PubMed ID: 10100395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
